This study aims to investigate whether adjunctive inspiratory muscle training (IMT) can enhance the benefits of pulmonary rehabilitation (PR) in patients with COVID-19. 120 patients will be randomized into an interventional group (PR plus IMT) and a control group (sham IMT plus PR). Improvement in quality of life, peak VO2 and VE/VCO2 slope will be defined as a primary outcome. Maximal inspiratory pressure, inspiratory muscle endurance, pulmonary function testing, severity of fatigue, cost-effectiveness and six minute walk test will be defined as the secondary outcomes.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
138
The patients are encouraged to inhale against a load to increase the inspiratory muscle strength and endurance
Secretaria de Saúde do Distrito Federal
Brasília, Federal District, Brazil
Cardiopulmonary Exercise Testing Measurements
Peak VO2 is a measurement of oxygen consumption rate during exercise (milliliters of oxygen per minute). It is calculated by continuous measurement of oxygen consumed during exercise while patients breath through a mask/tube. To account for variability in patient size, the oxygen consumption is divided by patient body weight.The VE/VCO2 slope is calculated as the ratio of minute ventilation (VE) and carbon dioxide production (VCO2). Because these measurements share the same units, the resultant ratio is unitless.The ventilatory anaerobic threshold (VAT) will be determined by the V-slope method.
Time frame: change from baseline in Peak VO2, VE/VCO2 slope and VAT at 8 weeks and 6 months
severity of fatigue
Fatigue severity scale (FSS) is a questionnaire consisting of 9 questions showing the degree of fatigue of patients. An average score of less than 2.8 indicates no fatigue, and more than 6.1 indicates chronic fatigue syndrome
Time frame: change from baseline in FSS score at 8 weeks and 6 months
Anxiety and Depression
Hospital anxiety and depression scale (HADS) is a 14-item questionnaire for screening anxiety (7 items) and depression (7 items). Each item is scored from 0-3 (a 4-point severity scale). Highest anxiety or depression score is 21. Patients are defined as having anxiety or depression or both if the score is 8 or more in the each subscale.
Time frame: Change from baseline in HADS score at 8 weeks and 6 months
incremental cost-utility ratio
Utility will be measured by Quality Adjusted Life Year (QALYs) as estimated from responses to the Euroqol-5 Dimensions (EQ-5D 5L) health-related quality of life questionnaire. The questionnaire focuses on 5 dimensions: mobility, personal autonomy, current activities, pain/discomfort and anxiety/depression. For each of these dimensions, 5 answers are possible.
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Health- related quality of life
EQ-5D is a standardized tool for the assessment of quality of life in 5 different dimensions (Mobility, Self-Care, Usual Activities, Pain/Discomfort, Anxiety/Depression). Possible scores range from 1 (No problem) to 3 (Extreme problems) and each dimension are evaluated individually
Time frame: change from baseline in EQ-5D score at 8 weeks and 6 months
Pulmonary function testing
Spirometry will be performed with a spirometer (Microlab 3.500; CareFusion, Yorba Linda, CA, USA). Three forced expiration maneuvers will be performed for validity and reproducibility purposes according to ATS/ERS criteria, with patients sitting, in a room with controlled temperature, ambient pressure, and relative humidity. The following variables will be analyzed: (a) forced vital capacity (FVC, L), (b) forced expiratory volume in the first second (FEV1, L).
Time frame: change from baseline in FEV1 and FVC in Liters at 8 weeks and 6 months.
Dyspnea
The modified Medical Research Council Dyspnea Scale (mMRC). A score from 0-4 is used to classify the impact of dyspnea on physical function in patients with respiratory limitations. 0 represents a person who suffers from dyspnea only with strenuous exercise. 4 represents a person who are to breathless to leave the house, or breathless when dressing/undressing.
Time frame: change from baseline in mMRC score at 8 weeks and 6 months
Respiratory muscle strength
Pulmonary function test with Maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP) measurements
Time frame: change from baseline in MIP and MEP at 8 weeks and 6 months
Postural Control
postural control assessed by stabilometry test
Time frame: change from baseline in Postural stability test and fall risk test at 8 weeks
isometric knee extension strength
peripheral muscle stregnth assessed by isometric load dynamometer
Time frame: change from baseline in Nm at 8 weeks
displacement
outcomes assessed by baropodometry
Time frame: change from baseline in CM2 at 8 weeks
trajectory
outcome assessed by baropodometry
Time frame: change from baseline in CM2 at 8 weeks
isometric knee flexion strength
peripheral muscle stregnth assessed by isometric load dynamometer
Time frame: change from baseline in Nm at 8 weeks
dynamic balance
dynamic balance assessed by Mini-BEST testing
Time frame: change from baseline in Total score at 8 weeks
Sit to Stand Test
exercise capacity assessed by Sit to Stand test
Time frame: change from baseline in repetitions at 8 weeks